Pfizer, Inc. (PFE)
Industry: Major Pharmaceuticals
Popular Topics & Highlights
Analysis
Yesterday, Thursday, January 21, we saw neutral social sentiment for Pfizer, Inc. (PFE). We gave it a score of -1. There was a significant amount of activity, such as likes and shares, on social media.
Over the prior 7 days we calculated an average sentiment score of 15 (positive). Over the prior 14 days our AI scored an average sentiment of 26 (positive). And for the prior 30 days our social sentiment score for Pfizer, Inc. (PFE) is 23 (positive).
Related Companies
Abeona Therapeutics Inc. (ABEO)
AcelRx Pharmaceuticals, Inc. (ACRX)
Aclaris Therapeutics, Inc. (ACRS)
Adamas Pharmaceuticals, Inc. (ADMS)
Adamis Pharmaceuticals Corporation (ADMP)
Adial Pharmaceuticals, Inc (ADIL)
Aileron Therapeutics, Inc. (ALRN)
Akebia Therapeutics, Inc. (AKBA)
Akero Therapeutics Inc. (AKRO)
Alexion Pharmaceuticals, Inc. (ALXN)
Amicus Therapeutics, Inc. (FOLD)
Ampio Pharmaceuticals, Inc. (AMPE)
Aptevo Therapeutics Inc. (APVO)
Arbutus Biopharma Corporation (ABUS)
Arrowhead Pharmaceuticals, Inc. (ARWR)
ASLAN Pharmaceuticals Limited (ASLN)
Assembly Biosciences, Inc. (ASMB)
Assertio Therapeutics, Inc. (ASRT)
Auris Medical Holding AG (EARS)
Axsome Therapeutics, Inc. (AXSM)
BioMarin Pharmaceutical Inc. (BMRN)
Bio-Path Holdings, Inc. (BPTH)
BioXcel Therapeutics, Inc. (BTAI)
Bison Capital Acquisition Corp. (BCAC)
Blueprint Medicines Corporation (BPMC)
Bristol-Myers Squibb Company (BMY)
Calithera Biosciences, Inc. (CALA)
Capricor Therapeutics, Inc. (CAPR)
Catabasis Pharmaceuticals, Inc. (CATB)
Chembio Diagnostics, Inc. (CEMI)
China Sxt Pharmaceuticals Inc. (SXTC)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corcept Therapeutics Incorporated (CORT)
Corvus Pharmaceuticals, Inc. (CRVS)
Cyclacel Pharmaceuticals, Inc. (CYCC)
CymaBay Therapeutics Inc. (CBAY)
Diffusion Pharmaceuticals Inc. (DFFN)
Dynavax Technologies Corporation (DVAX)
Entasis Therapeutics Holdings Inc. (ETTX)
Evofem Biosciences, Inc. (EVFM)
Five Prime Therapeutics, Inc. (FPRX)
Flexion Therapeutics, Inc. (FLXN)
Heron Therapeutics, Inc. (HRTX)
Intercept Pharmaceuticals, Inc. (ICPT)
Intra-Cellular Therapies Inc. (ITCI)
Iterum Therapeutics plc (ITRM)
Kala Pharmaceuticals, Inc. (KALA)
Karyopharm Therapeutics Inc. (KPTI)
Kezar Life Sciences, Inc. (KZR)
Lexicon Pharmaceuticals, Inc. (LXRX)
Marinus Pharmaceuticals, Inc. (MRNS)
Mersana Therapeutics, Inc. (MRSN)
Milestone Pharmaceuticals Inc. (MIST)
Minerva Neurosciences, Inc (NERV)
Mirati Therapeutics, Inc. (MRTX)
MYOS RENS Technology Inc. (MYOS)
Nabriva Therapeutics plc (NBRV)
Neos Therapeutics, Inc. (NEOS)
NovaBay Pharmaceuticals, Inc. (NBY)
Ocular Therapeutix, Inc. (OCUL)
Onconova Therapeutics, Inc. (ONTX)
Oncternal Therapeutics Inc. (ONCT)
Organogenesis Holdings Inc. (ORGO)
Palatin Technologies, Inc. (PTN)
Principia Biopharma Inc. (PRNB)
Regeneron Pharmaceuticals, Inc. (REGN)
Rigel Pharmaceuticals, Inc. (RIGL)
Rocket Pharmaceuticals, Inc. (RCKT)
Sage Therapeutics, Inc. (SAGE)
Sarepta Therapeutics, Inc. (SRPT)
Satsuma Pharmaceuticals Inc. (STSA)
SELLAS Life Sciences Group, Inc. (SLS)
Seres Therapeutics, Inc. (MCRB)
Sonoma Pharmaceuticals, Inc. (SNOA)
Spectrum Pharmaceuticals, Inc. (SPPI)
Sunesis Pharmaceuticals, Inc. (SNSS)
Synthetic Biologics, Inc (SYN)
Taiwan Liposome Company, Ltd. (TLC)
Teva Pharmaceutical Industries Limited (TEVA)
TFF Pharmaceuticals Inc. (TFFP)
Tiziana Life Sciences plc (TLSA)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Trillium Therapeutics Inc. (TRIL)
Unity Biotechnology, Inc. (UBX)
Vertex Pharmaceuticals Incorporated (VRTX)
VistaGen Therapeutics, Inc. (VTGN)
Xenetic Biosciences, Inc. (XBIO)
Zomedica Pharmaceuticals Corp. (ZOM)
Disclaimer
We believe social network activity can help inform investors of the positive and negative opinions people hold of a company. Social media posts are made both before and after market price fluctuations. We can make no claim of causation or future correlation between market prices and social media sentiment. We make no evaluation of stock value and we can make no prediction of future prices. The information gathered on SocialSentiment.io should be only one part of a broader investment strategy.
We've trained our artificial intelligence systems from past social media posts. While tests show our predictions are usually accurate to our models, a human may come to a different conclusion for some posts.
